Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Complement Factor H anticorps (FITC)

Cet anticorps Souris Monoclonal détecte spécifiquement Complement Factor H dans WB, EIA et IHC (fro). Il présente une réactivité envers Rat et Souris.
N° du produit ABIN5540273

Aperçu rapide pour Complement Factor H anticorps (FITC) (ABIN5540273)

Antigène

Voir toutes Complement Factor H (CFH) Anticorps
Complement Factor H (CFH)

Reactivité

  • 72
  • 11
  • 11
  • 2
  • 2
Rat, Souris

Hôte

  • 57
  • 26
  • 3
  • 2
Souris

Clonalité

  • 53
  • 34
  • 1
Monoclonal

Conjugué

  • 55
  • 10
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp Complement Factor H est conjugé à/à la FITC

Application

  • 64
  • 35
  • 26
  • 22
  • 19
  • 16
  • 13
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

1A2
  • Specificité

    The monoclonal antibody 1A2 recognizes Mouse complement factor H (CFH).

    Immunogène

    Mouse factor H-human IgG fusion protein.

    Isotype

    IgG1
  • Indications d'application

    Immuno Assays. Western blot . Immunohistochemistry on Frozen Sections The typical starting working dilution is 1/50.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store undiluted at 2-8°C. DO NOT FREEZE! This product is photosensitive and should be protected from light. Shelf life: one year from despatch.

    Date de péremption

    12 months
  • Antigène

    Complement Factor H (CFH)

    Sujet

    CFH is the first regulatory protein of the alternative pathway of the complement system. There are three pathways of complement activation classical, alternative, and lectin activation pathway. These pathways converge to form C3/C5 convertases that generate C3a, C3b,C5a, and C5b, each with substantial biologic activity. Complement regulators are necessary to prevent the injudicious production of these mediators and potential injury to self-tissue. The plasma proteins CFH, C4-binding protein and the cell membrane proteins complement receptor 1 (CR1 CD35), decay-accelerating factor (CD55), and membrane co-factor protein (CD46) all are members of the regulators of complement activation family. These proteins have natural affinity for C3b and/or C4b, which confers on them the ability to accelerate the intrinsic decay of C3/C5 convertases and/or act as co-factor for the cleavage and inactivation (i) of C3b and C4b by complement factor I (CFI). Genetic human analyses reveals a clear association of CFH with different human diseases. These include diseases of the kidney, the atypical form of Hemolytic Uremic Syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN). Furthermore, CFH is associated with age-related macular degeneration (AMD), a disease of the eye.

    UniProt

    P06909

    Pathways

    Système du Complément, Cellular Response to Molecule of Bacterial Origin
Vous êtes ici:
Chat with us!